AUF1-induced Circular RNA Hsa_circ_0010467 Promotes Platinum Resistance of Ovarian Cancer Through MiR-637/LIF/STAT3 Axis

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2023 Aug 17

PMID 37589744

Authors

Yangjun Wu

Miao Xu

Zheng Feng

Hao Wu

Jingni Wu

Xinyu Ha

Yong Wu

Siyu Chen

Fei Xu

Hao Wen

Shengli Li

Xiaohua Wu

Affiliations

Soon will be listed here.

Abstract

Background: Increasing evidences has indicated that primary and acquired resistance of ovarian cancer (OC) to platinum is mediated by multiple molecular and cellular factors. Understanding these mechanisms could promote the therapeutic efficiency for patients with OC.

Methods: Here, we screened the expression pattern of circRNAs in samples derived from platinum-resistant and platinum-sensitive OC patients using RNA-sequencing (RNA-seq). The expression of hsa_circ_0010467 was validated by Sanger sequencing, RT-qPCR, and fluorescence in situ hybridization (FISH) assays. Overexpression and knockdown experiments were performed to explore the function of hsa_circ_0010467. The effects of hsa_circ_0010467 on enhancing platinum treatment were validated in OC cells, mouse model and patient-derived organoid (PDO). RNA pull-down, RNA immunoprecipitation (RIP), and dual-luciferase reporter assays were performed to investigate the interaction between hsa_circ_0010467 and proteins.

Results: Increased expression of hsa_circ_0010467 is observed in platinum-resistant OC cells, tissues and serum exosomes, which is positively correlated with advanced tumor stage and poor prognosis of OC patients. Hsa_circ_0010467 is found to maintain the platinum resistance via inducing tumor cell stemness, and silencing hsa_circ_0010467 substantially increases the efficacy of platinum treatment on inhibiting OC cell proliferation. Further investigation reveals that hsa_circ_0010467 acts as a miR-637 sponge to mediate the repressive effect of miR-637 on leukemia inhibitory factor (LIF) and activates the LIF/STAT3 signaling pathway. We further discover that AUF1 could promote the biogenesis of hsa_circ_0010467 in OC.

Conclusion: Our study uncovers the mechanism that hsa_circ_0010467 mediates the platinum resistance of OC through AUF1/hsa_circ_0010467/miR-637/LIF/STAT3 axis, and provides potential targets for the treatment of platinum-resistant OC patients.

Citing Articles

CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p/SLC7A11 axis.

Zhang Y, Yao R, Li M, Fang C, Feng K, Chen X Mol Cancer. 2025; 24(1):32.

PMID: 39871338 PMC: 11771119. DOI: 10.1186/s12943-024-02224-3.

EIF4A3-induced circ_0022382 promotes breast cancer cell progression through the let-7a-5p/PI3K/AKT/mTOR signaling pathway and SLC7A11 axis.

Liu W, Zhang J, Zhang J, Ye Y, Zhu J, Yu Q Front Oncol. 2025; 14:1476731.

PMID: 39868374 PMC: 11758171. DOI: 10.3389/fonc.2024.1476731.

Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities.

Li J, Zhou W, Wang H, Huang M, Deng H MedComm (2020). 2024; 5(12):e70019.

PMID: 39584047 PMC: 11586091. DOI: 10.1002/mco2.70019.

Interplay of microRNAs and circRNAs in Epithelial Ovarian Cancer.

Schwarzenbach H Noncoding RNA. 2024; 10(5).

PMID: 39452837 PMC: 11510331. DOI: 10.3390/ncrna10050051.

Exosomes: Key Factors in Ovarian Cancer Peritoneal Metastasis and Drug Resistance.

Shao M, Gao Y, Xu X, Chan D, Du J Biomolecules. 2024; 14(9).

PMID: 39334866 PMC: 11430201. DOI: 10.3390/biom14091099.

References

Zhang J, He M, Fu W, Wang H, Chen L, Zhu X . Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling. Hepatology. 2011; 54(6):2137-48. DOI: 10.1002/hep.24595. View

Glazar P, Papavasileiou P, Rajewsky N . circBase: a database for circular RNAs. RNA. 2014; 20(11):1666-70. PMC: 4201819. DOI: 10.1261/rna.043687.113. View

Gao W, Guo H, Niu M, Zheng X, Zhang Y, Xue X . circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway. Mol Cancer. 2020; 19(1):166. PMC: 7686732. DOI: 10.1186/s12943-020-01279-2. View

Chen L, Kong R, Wu C, Wang S, Liu Z, Liu S . Circ-MALAT1 Functions as Both an mRNA Translation Brake and a microRNA Sponge to Promote Self-Renewal of Hepatocellular Cancer Stem Cells. Adv Sci (Weinh). 2020; 7(4):1900949. PMC: 7029649. DOI: 10.1002/advs.201900949. View

Budiana I, Angelina M, Pemayun T . Ovarian cancer: Pathogenesis and current recommendations for prophylactic surgery. J Turk Ger Gynecol Assoc. 2018; 20(1):47-54. PMC: 6501866. DOI: 10.4274/jtgga.galenos.2018.2018.0119. View

Kopper O, de Witte C, Lohmussaar K, Espejo Valle-Inclan J, Hami N, Kester L . An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat Med. 2019; 25(5):838-849. DOI: 10.1038/s41591-019-0422-6. View

Zhou S, Dai Q, Huang X, Jin A, Yang Y, Gong X . STAT3 is critical for skeletal development and bone homeostasis by regulating osteogenesis. Nat Commun. 2021; 12(1):6891. PMC: 8616950. DOI: 10.1038/s41467-021-27273-w. View

Que T, Song Y, Liu Z, Zheng S, Long H, Li Z . Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1. Oncogene. 2015; 34(38):4952-63. DOI: 10.1038/onc.2014.419. View

Fang Z, Jiang C, Li S . The Potential Regulatory Roles of Circular RNAs in Tumor Immunology and Immunotherapy. Front Immunol. 2021; 11:617583. PMC: 7886782. DOI: 10.3389/fimmu.2020.617583. View

10.

Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N . The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25(16):2078-9. PMC: 2723002. DOI: 10.1093/bioinformatics/btp352. View

11.

Chen M, Yang S, Chien M, Hua K, Wu C, Hsiao S . The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer. Cancer Res. 2017; 77(8):1955-1967. DOI: 10.1158/0008-5472.CAN-16-1115. View

12.

Feng Z, Zheng L, Yao T, Tao S, Wei X, Zheng Z . EIF4A3-induced circular RNA PRKAR1B promotes osteosarcoma progression by miR-361-3p-mediated induction of FZD4 expression. Cell Death Dis. 2021; 12(11):1025. PMC: 8556261. DOI: 10.1038/s41419-021-04339-7. View

13.

Dudekula D, Panda A, Grammatikakis I, De S, Abdelmohsen K, Gorospe M . CircInteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2015; 13(1):34-42. PMC: 4829301. DOI: 10.1080/15476286.2015.1128065. View

14.

Friedman R, Farh K, Burge C, Bartel D . Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2008; 19(1):92-105. PMC: 2612969. DOI: 10.1101/gr.082701.108. View

15.

Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z . clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021; 2(3):100141. PMC: 8454663. DOI: 10.1016/j.xinn.2021.100141. View

16.

Zhao Z, Ji M, Wang Q, He N, Li Y . Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer via miR-1270 Suppression. Mol Ther Nucleic Acids. 2019; 18:24-33. PMC: 6726918. DOI: 10.1016/j.omtn.2019.07.012. View

17.

Wang L, Jiang F, Xia X, Zhang B . LncRNA FAL1 promotes carcinogenesis by regulation of miR-637/NUPR1 pathway in colorectal cancer. Int J Biochem Cell Biol. 2018; 106:46-56. DOI: 10.1016/j.biocel.2018.09.015. View

18.

Penuelas S, Anido J, Prieto-Sanchez R, Folch G, Barba I, Cuartas I . TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell. 2009; 15(4):315-27. DOI: 10.1016/j.ccr.2009.02.011. View

19.

Wen Y, Hou Y, Yi X, Sun S, Guo J, He X . EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells. Theranostics. 2021; 11(4):1795-1813. PMC: 7778604. DOI: 10.7150/thno.48101. View

20.

Bolger A, Lohse M, Usadel B . Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014; 30(15):2114-20. PMC: 4103590. DOI: 10.1093/bioinformatics/btu170. View